Clinical Outcomes of Autologous Bone Marrow Aspirate Concentrate Injections for Musculoskeletal Conditions
Withdrawn before enrolling
Conditions studied: Musculoskeletal Pain, Osteoarthritis, Tendinopathy, Sprains Strain
In brief
The use of Bone Marrow Autologous Collection (BMAC) in musculoskeletal conditions including osteoarthritis and tendon injuries has been growing. Outcome evidence continues to be sparse. The purpose of this study is collect a longitudinal case series of patient reported outcomes following BMAC injections for musculoskeletal conditions including osteoarthritis, tendinopathy and injuries to ligaments, tendons and muscles.
Key facts
- Study ID
- NCT02981394
- Run by
- Rush University Medical Center
- People needed
- 0
- Starts
- 2016-11-01
- Expected to finish
- 2021-01-01
- Last updated by the study team
- 2021-05-27
Who can join
Age: 18 and older, up to 90. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Musculoskeletal Condition that is able to undergo an injection
- Patient requests the procedure and enrolls with agreement to pay for the procedure
You may not qualify if…
- Active Cancer
- Allergies to local anesthesia
Where it is running
- Midwest Orthopeadics at Rush — Chicago, Illinois, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.